Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s11926-021-01037-3

http://scihub22266oqcxt.onion/10.1007/s11926-021-01037-3
suck pdf from google scholar
34269903!8284038!34269903
unlimited free pdf from europmc34269903    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34269903      Curr+Rheumatol+Rep 2021 ; 23 (9): 74
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections) #MMPMID34269903
  • Varley CD; Winthrop KL
  • Curr Rheumatol Rep 2021[Jul]; 23 (9): 74 PMID34269903show ga
  • PURPOSE OF REVIEW: We reviewed the current data on infections associated with rituximab use published over the last 5 years. RECENT FINDINGS: New literature was available on rates of serious infections, Hepatitis B reactivation and screening, and infection with Severe Acute Respiratory Syndrome Coronavirus 2. Rates of infection varied by study and population, however, higher risk of infection in patients with underlying rheumatologic diseases was seen in those who required a therapy switch, had a smoking history, and those undergoing retreatment who had a serious infection with their first course of therapy. With regards to HBV, the proportion of patients screened continues to be inadequate. Despite the upfront cost, HBV screening and prophylaxis were found to be cost effective. There is still limited data regarding COVID-19 severity in the setting of rituximab, however, rituximab, especially in combination with steroids, may lead to more severe disease and higher mortality.
  • |Antirheumatic Agents/*therapeutic use[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |COVID-19/*epidemiology[MESH]
  • |Hepatitis B/diagnosis/drug therapy/*epidemiology/prevention & control[MESH]
  • |Humans[MESH]
  • |Immunocompromised Host[MESH]
  • |Latent Infection/diagnosis/drug therapy/epidemiology/prevention & control[MESH]
  • |Mass Screening[MESH]
  • |Opportunistic Infections/*epidemiology[MESH]
  • |Risk[MESH]
  • |Rituximab/*therapeutic use[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box